BioCentury
ARTICLE | Company News

Innocutis, Onxeo sales and marketing update

August 11, 2014 7:00 AM UTC

Innocutis launched Sitavig acyclovir 50 mg buccal tablet in North America to treat recurrent herpes labialis. Innocutis has exclusive North American commercialization rights to the mucoadhesive formu...